Forced Expiratory Flow (FEF25–75%) as a Clinical Endpoint in Children and Adolescents with Symptomatic Asthma Receiving Tiotropium: A Post Hoc Analysis
figure
posted on 2020-05-05, 14:48 authored by Stanley J. Szefler, Stanley Goldstein, Christian Vogelberg, George W. Bensch, John Given, Branko Jugovic, Michael Engel, Petra M. Moroni-Zentgraf, Ralf Sigmund, Eckard H. Hamelmann<p><strong>Article full
text</strong></p>
<p><br>
The article associated with this page has been accepted for
online publication and is in the final stages of production. The link to the
full text will be made available on this page in the next few days.</p>
<p><br>
The above Summary Slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC 2020.<b>
</b></p>
